Whole-brain N-acetylaspartate Level and Cognitive Performance in HIV Infection

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2003 Sep 19

PMID 13679275

Citations 12

Authors

Sohil H Patel

Matilde Inglese

Guila Glosser

Dennis L Kolson

Robert I Grossman

Oded Gonen

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: In the brain of HIV-infected patients, proton MR spectroscopic studies are typically used to examine small volumes of tissue with single-voxel methods. Since brain disease is diffuse in patients with HIV, such studies preclude assessment of the true extent of the metabolic burden. To assess this extent, the relationship between global neuronal integrity, reflected by the whole-brain N-acetylaspartate (WBNAA) concentration, was correlated with neuropsychological function and the AIDS dementia complex (ADC) stage score.

Methods: WBNAA levels were compared between 15 HIV-infected patients (seven symptomatic, eight asymptomatic) and 13 age- and sex-matched healthy subjects. The patients' WBNAA level was correlated with cognitive performance, as measured with a battery of eight tests (NPZ-8), including the ADC stage score and four total-memory, mood, motor, and processing speed subtests.

Results: WBNAA levels were significantly different between patients and healthy subjects (mean +/- sigma, 11.82 +/- 1.40 and 12.91 +/- 1.03 mmol/L, respectively; P =.032) after we adjusted for age and sex effects. Intermediate negative correlations were found between the WBNAA level, the processing speed subtest score (r = -0.50, P =.03), and the ADC stage score (r = -0.44, P =.05).

Conclusion: The WBNAA concentration complements brain atrophy data with information about the quality of the remaining neuronal and axonal tissue in patients with HIV infection. In HIV-infected patients, its correlation with processing speed and the ADC score indicates that the latter reflects pathologic deficits, which are extensive throughout the brain.

Citing Articles

Executive function and processing speed in Brazilian HIV-infected children and adolescents.

Haase V, Nicolau N, Viana V, Barreto G, Pinto J Dement Neuropsychol. 2017; 8(1):32-39.

PMID: 29213877 PMC: 5619446. DOI: 10.1590/S1980-57642014DN81000006.

Management of Viral Central Nervous System Infections: A Primer for Clinicians.

Bookstaver P, Mohorn P, Shah A, Tesh L, Quidley A, Kothari R J Cent Nerv Syst Dis. 2017; 9:1179573517703342.

PMID: 28579869 PMC: 5415352. DOI: 10.1177/1179573517703342.

Imaging in viral infections of the central nervous system: can images speak for an acutely ill brain?.

Maller V, Bathla G, Moritani T, Helton K Emerg Radiol. 2016; 24(3):287-300.

PMID: 27853972 DOI: 10.1007/s10140-016-1463-5.

Automated whole-brain N-acetylaspartate proton MRS quantification.

Soher B, Wu W, Tal A, Storey P, Zhang K, Babb J NMR Biomed. 2014; 27(11):1275-84.

PMID: 25196714 PMC: 4212831. DOI: 10.1002/nbm.3185.

Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment.

Hua X, Boyle C, Harezlak J, Tate D, Yiannoutsos C, Cohen R Neuroimage Clin. 2013; 3:132-42.

PMID: 24179857 PMC: 3791291. DOI: 10.1016/j.nicl.2013.07.009.

References

Lopez-Villegas D, Lenkinski R, Frank I . Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A. 1997; 94(18):9854-9. PMC: 23281. DOI: 10.1073/pnas.94.18.9854. View

Moller H, Vermathen P, Lentschig M, Schuierer G, Schwarz S, Wiedermann D . Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging. 1999; 9(1):10-8. DOI: 10.1002/(sici)1522-2586(199901)9:1<10::aid-jmri2>3.0.co;2-w. View

Jarvik J, Lenkinski R, Grossman R, Gomori J, SCHNALL M, Frank I . Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology. 1993; 186(3):739-44. DOI: 10.1148/radiology.186.3.8430182. View

Gonen O, Viswanathan A, Catalaa I, Babb J, Udupa J, Grossman R . Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med. 1998; 40(5):684-9. DOI: 10.1002/mrm.1910400506. View

Bencherif B, Rottenberg D . Neuroimaging of the AIDS dementia complex. AIDS. 1998; 12(3):233-44. View

Power C, Kong P, Crawford T, Wesselingh S, Glass J, McArthur J . Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol. 1993; 34(3):339-50. DOI: 10.1002/ana.410340307. View

Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D . Neuropathology of early HIV-1 infection. Brain Pathol. 1996; 6(1):1-15. DOI: 10.1111/j.1750-3639.1996.tb00775.x. View

McConnell J, Swindells S, Ong C, Gmeiner W, Chu W, Brown D . Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring HIV infection and its associated neurological impairment. AIDS Res Hum Retroviruses. 1994; 10(8):977-82. DOI: 10.1089/aid.1994.10.977. View

. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Neurology. 1998; 50(3):645-51. DOI: 10.1212/wnl.50.3.645. View

10.

Patel S, Kolson D, Glosser G, Matozzo I, Ge Y, Babb J . Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients. AJNR Am J Neuroradiol. 2002; 23(4):543-9. PMC: 7975102. View

11.

Navia B, Dafni U, Simpson D, Tucker T, Singer E, McArthur J . A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology. 1998; 51(1):221-8. DOI: 10.1212/wnl.51.1.221. View

12.

Ernst T, Itti E, Itti L, Chang L . Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study. J Magn Reson Imaging. 2000; 12(6):859-65. DOI: 10.1002/1522-2586(200012)12:6<859::aid-jmri8>3.0.co;2-t. View

13.

Pomara N, Crandall D, Choi S, Johnson G, Lim K . White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 2001; 106(1):15-24. DOI: 10.1016/s0925-4927(00)00082-2. View

14.

McArthur J, Sacktor N, Selnes O . Human immunodeficiency virus-associated dementia. Semin Neurol. 2000; 19(2):129-50. DOI: 10.1055/s-2008-1040831. View

15.

Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A . HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology. 1996; 199(3):805-10. DOI: 10.1148/radiology.199.3.8638009. View

16.

Meyerhoff D, Mackay S, Bachman L, Poole N, Dillon W, Weiner M . Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology. 1993; 43(3 Pt 1):509-15. DOI: 10.1212/wnl.43.3_part_1.509. View

17.

Chang L, Ernst T, Walot I, Singer E . Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 1999; 52(1):100-8. DOI: 10.1212/wnl.52.1.100. View

18.

. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology. 1996; 47(5):1247-53. DOI: 10.1212/wnl.47.5.1247. View

19.

Filippi C, Ulug A, Ryan E, Ferrando S, Van Gorp W . Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol. 2001; 22(2):277-83. PMC: 7973937. View

20.

Simmons M, Frondoza C, Coyle J . Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991; 45(1):37-45. DOI: 10.1016/0306-4522(91)90101-s. View